202
Participants
Start Date
November 13, 2024
Primary Completion Date
November 30, 2029
Study Completion Date
June 30, 2030
ABSK061 + ABSK043
Participants with fibroblast growth factor receptor (FGFR) mutations and FGFR gene fusions will receive a dose of ABSK061 + ABSK043 oral capsule until disease progression, intolerable toxicity, withdrawal of consent, decision by the investigator to discontinue treatment, or end of data collection timepoint if there is clinical benefit in the opinion of the investigator, has been achieved.
ABSK061+ABSK043 in combination with CAPOX
Participants with HER2-Gastric/Gastroesophageal Junction Cancer and fibroblast growth factor receptor 2( FGFR2 ) amplification and overexpression will receive a dose of ABSK061 + ABSK043 oral capsule in combination with CAPOX until disease progression, intolerable toxicity, withdrawal of consent, decision by the investigator to discontinue treatment, or end of data collection timepoint if there is clinical benefit in the opinion of the investigator, has been achieved.
NOT_YET_RECRUITING
Liaoning Cancer Hospital and Institute, Shenyang
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
ZhongShan Hospital Fudan University, Shanghai
NOT_YET_RECRUITING
Cancer Hospital of Shandong First Medical University, Jinan
NOT_YET_RECRUITING
Jiangxi Cance Hospital, Nanchang
NOT_YET_RECRUITING
Hunan Central Hospital, Changsha
NOT_YET_RECRUITING
Henan Cancer Hospital, Zhengzhou
NOT_YET_RECRUITING
Guizhou Provincial People'S Hospital, Guiyang
NOT_YET_RECRUITING
The Affiliated Hospital of Guizhou Medical University, Guiyang
NOT_YET_RECRUITING
Xiangyang Central Hospital, Xiangyang
NOT_YET_RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
NOT_YET_RECRUITING
Changzhi People's Hospital, Changzhi
NOT_YET_RECRUITING
West China Hospital, Sichuan University, Chengdu
NOT_YET_RECRUITING
The First Hospital of China Medical University, Hangzhou
NOT_YET_RECRUITING
Zhejiang Provincial People'S Hospital, Hangzhou
NOT_YET_RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
NOT_YET_RECRUITING
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan
NOT_YET_RECRUITING
First Hospital of Shanxi Medical University, Xi'an
NOT_YET_RECRUITING
Shanxi Cancer hospital (Shanxi Cancer institute), Xi'an
NOT_YET_RECRUITING
First Affiliated Hospital of Xiamen University, Xiamen
NOT_YET_RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Lead Sponsor
Abbisko Therapeutics Co, Ltd
INDUSTRY